Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral neuropathies associated with monoclonal proteins

E P Bosch1, B E Smith

  • 1Section of Neurology, Mayo Clinic Scottsdale, Arizona.

The Medical Clinics of North America
|January 1, 1993
PubMed
Summary

Peripheral neuropathies linked to monoclonal proteins, often MGUS, can be demyelinating or axonal. Some neuropathies show autoimmune links, but causality remains unproven.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indefinite Pain, Its Cause as Viewed by the Dowd Phosphatometer.

Buffalo medical journal·2023
Same author

Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath.

Journal of analytical toxicology·2021
Same author

Biological and environmental drivers of trophic ecology in marine fishes - a global perspective.

Scientific reports·2019
Same author

Understanding the Haemodynamics of Hypertension.

Current hypertension reports·2018
Same author

Stroke Volume Monitoring: Novel Continuous Wave Doppler Parameters, Algorithms and Advanced Noninvasive Haemodynamic Concepts.

Current anesthesiology reports·2017
Same author

Peripheral Neuropathy Caused by Proteolipid Protein Gene Mutations.

Annals of the New York Academy of Sciences·2017

Area of Science:

  • Neurology
  • Immunology
  • Oncology

Background:

  • Peripheral neuropathies are often associated with monoclonal proteins, particularly in cases of unknown cause (MGUS).
  • Associated disorders include multiple myeloma, AL amyloidosis, Waldenström's macroglobulinemia, and lymphoma.
  • Neuropathies can be demyelinating or axonal, with varying prognoses and treatment responses.

Purpose of the Study:

  • To review the clinical significance and underlying mechanisms of peripheral neuropathies associated with monoclonal proteins.
  • To explore the role of autoantibodies against nerve antigens in specific neuropathy syndromes.
  • To discuss the evidence for autoimmune mechanisms and the challenges in establishing causality.

Main Methods:

  • Review of existing literature on monoclonal protein-associated neuropathies.
  • Analysis of clinical presentations, disease courses, and treatment outcomes.
  • Discussion of serological findings, including anti-MAG and anti-GM1 ganglioside antibodies.

Main Results:

  • Demyelinating neuropathies, especially IgM-associated, often respond to immunotherapy.
  • Axonal neuropathies linked to MGUS, myeloma, or amyloidosis typically do not respond to therapy.
  • Specific autoantibodies (anti-MAG, anti-GM1) are found in distinct neuropathy syndromes, suggesting immune involvement.

Conclusions:

  • Autoimmune mechanisms are increasingly implicated in some monoclonal protein-associated neuropathies.
  • The causal link between monoclonal proteins and these neurological syndromes requires further investigation.
  • Understanding these associations is crucial for diagnosis and therapeutic strategies.

Related Experiment Videos